Amman: Jordan Food and Drug Administration (JFDA) underlined the importance of administering intravenous iron infusions under medical supervision to ensure "correct" dosage and prevent potential health complications, primarily allergic reactions that may require emergency procedures due to the rare but serious risk to life. In a statement issued Sunday, the JFDA detailed that allergic reactions can surface as mild symptoms, mainly skin rash, itching, redness, a feeling of warmth or tingling, slight swelling in the face or hands, shortness of breath or wheezing, while the acute symptoms can involve anaphylactic shock, mainly severe difficulty in breathing, rapid or irregular heartbeat, and significant drops in blood pressure. The JFDA advised people, who suffered these symptoms after receiving an iron infusion, should immediately seek medical attention at the nearest hospital or emergency center. Source: Jordan News Agency
JFDA Advises Medical Supervision for Iron infusions to Avoid Health Risks
Al-Qalaa Team Wins Hoban Stars Youth League in Thrilling Final
October 24, 2025
SPC Member Extends Condolences to Sheikh Ali al-Dhubaibi
October 24, 2025
Mass Gatherings in Sana’a Pay Tribute to Martyrs’ Blood
October 24, 2025